Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT – Virtual Press Office (press release)

Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT
Virtual Press Office (press release)
In preparation for listing on the NYSE MKT, the Company simplified its capital structure with the completion of the previously announced distribution of BioTime, Inc. common share purchase warrants to holders of Asterias Series A common stock, and with

and more

…read more

Scroll to Top